|
Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine >
Peer-reviewed Journal Articles, etc >
Inhibition of Survivin Influences the Biological Activities of Canine Histiocytic Sarcoma Cell Lines
This item is licensed under:Creative Commons Attribution 3.0 Unported
| Title: | Inhibition of Survivin Influences the Biological Activities of Canine Histiocytic Sarcoma Cell Lines |
| Authors: | Yamazaki, Hiroki Browse this author | | Takagi, Satoshi Browse this author →KAKEN DB | | Hoshino, Yuki Browse this author →KAKEN DB | | Hosoya, Kenji Browse this author | | Okumura, Masahiro Browse this author →KAKEN DB |
| Issue Date: | 15-Nov-2013 |
| Publisher: | Public Library of Science |
| Journal Title: | PLoS One |
| Volume: | 8 |
| Issue: | 11 |
| Start Page: | 1 |
| End Page: | 11 |
| Publisher DOI: | 10.1371/journal.pone.0079810 |
| Abstract: | Canine histiocytic sarcoma (CHS) is an aggressive malignant neoplasm that originates from histiocytic lineage cells, including dendritic cells and macrophages, and is characterized by progressive local infiltration and a very high metastatic potential. Survivin is as an apoptotic inhibitory factor that has major functions in cell proliferation, including inhibition of apoptosis and regulation of cell division, and is expressed in most types of human and canine malignant neoplasms, including melanoma and osteosarcoma. To investigate whether survivin was expressed at high levels in CHS and whether its expression was correlated with the aggressive biological behavior of CHS, we assessed relation between survivin expression and CHS progression, as well as the effects of survivin inhibition on the biological activities of CHS cells. We comparatively analyzed the expression of 6 selected anti-apoptotic genes, including survivin, in specimens from 30 dogs with histiocytic sarcoma and performed annexin V staining to evaluate apoptosis, methylthiazole tetrazolium assays to assess cell viability and chemosensitivity, and latex bead assays to measure changes in phagocytic activities in 4 CHS cell lines and normal canine fibroblasts transfected with survivin siRNA. Survivin gene expression levels in 30 specimens were significantly higher than those of the other 6 genes. After transfection with survivin siRNA, apoptosis, cell growth inhibition, enhanced chemosensitivity, and weakened phagocytic activities were observed in all CHS cell lines. In contrast, normal canine fibroblasts were not significantly affected by survivin knockdown. These results suggested that survivin expression may mediate the aggressive biological activities of CHS and that survivin may be an effective therapeutic target for the treatment of CHS. |
| Rights: | http://creativecommons.org/licenses/by/3.0/ |
| Type: | article |
| URI: | http://hdl.handle.net/2115/54598 |
| Appears in Collections: | 獣医学院・獣医学研究院 (Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 奥村 正裕
|
